Ringe J D, Dorst A J
Klinikum Leverkusen, Medizinische Klinik 4, Universität zu Köln.
Ther Umsch. 1998 Nov;55(11):717-23.
The prevalence of osteoporosis in men has been underestimated in the past. Vertebral fractures were found in about 10% in men of age 50 and over 20 to 30% of all hip fractures in advanced age occur in men. Lower life expectancy of men but also differences in bone geometry and remodeling contribute to the lower rate of fractures in comparison to the female gender. In men with suspected osteoporosis a thorough history, physical and clinical examination is mandatory to exclude other localized or generalized osteopathies and to differentiate in primary and secondary osteoporosis. Only some small studies have been published so far on treatment of osteoporosis in men, i.e. therapeutic decisions are mainly based on existing results in postmenopausal osteoporosis. The basis of treatment is calcium and vitamin D supplementation and individually adapted recommendations on life style and risk factor avoidance. In established osteoporosis in adequate analgesic therapy is very important. In cases with secondary osteoporosis, if possible, etiological therapy should be started. Antiresorptive therapy (e.g. calcitonin, bisphosphonates) or osteoanabolic therapy (e.g. fluoride) can later be added, while in idiopathic osteoporosis this is the first option. According to the existing experiences there is in general a good chance to ameliorate the condition in men. There is however an urgent need for further data on therapy of osteoporosis in men.
过去,男性骨质疏松症的患病率一直被低估。在50岁及以上的男性中,约10%存在椎体骨折,而在高龄男性中,所有髋部骨折中有20%至30%发生在男性身上。男性预期寿命较低,以及骨几何形状和重塑的差异,导致与女性相比骨折发生率较低。对于疑似骨质疏松症的男性,必须进行全面的病史、体格和临床检查,以排除其他局部或全身性骨病,并区分原发性和继发性骨质疏松症。到目前为止,关于男性骨质疏松症治疗的研究只有一些小型研究发表,也就是说,治疗决策主要基于绝经后骨质疏松症的现有结果。治疗的基础是补充钙和维生素D,以及根据个人情况调整生活方式和避免危险因素的建议。对于确诊的骨质疏松症,充分的镇痛治疗非常重要。对于继发性骨质疏松症患者,如有可能,应开始病因治疗。后期可添加抗吸收治疗(如降钙素、双膦酸盐)或骨合成代谢治疗(如氟化物),而对于特发性骨质疏松症,这是首选治疗方法。根据现有经验,总体而言,改善男性病情的机会很大。然而,迫切需要更多关于男性骨质疏松症治疗的数据。